相关实验视频
Updated: Jun 18, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.2K
概括
了解美国药物定价对于神经病学家来说至关重要. 这包括分析供应链,利益相关者以及新神经病治疗的成本效益,特别是最近的立法变化.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 神经学 神经学
背景情况:
- 创新的神经病药物需要考虑成本,有效性和安全性.
- 美国处方药定价格格局是复杂的,涉及许多利益相关者.
- 最近的立法,比如2022年通货膨胀减缓法案,影响了医疗保险受益人的药物成本.
研究的目的:
- 阐明美国毒品分销供应链,并确定关键利益相关者.
- 定义基本的药物定价术语.
- 为评估新的神经病药物引入成本效益概念.
主要方法:
- 美国毒品分销系统的描述性分析.
- 解释药品定价机制和利益相关者的角色.
- 折扣估计和成本效益分析的概述.
主要成果:
- 美国药品供应链包括制造商,批发商,药房,PBM,付款人,医院,临床医生和患者.
- 概述了关键的定价条款和折扣估计流程.
- 介绍了成本效益术语,以评估神经病学中的药物价值.
结论:
- 神经科医生需要了解药物定价和供应链,以便做出明智的治疗决策.
- "降低通货膨胀法案"对医疗保险药品成本进行了重大变化.
- 评估新的神经病药物需要考虑临床效用和经济价值.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
711
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
711
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Drug Delivery: Parenteral Route
460
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
460
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K

